Inhibition of Wnt signaling induces cell apoptosis and suppresses cell proliferation in cholangiocarcinoma cells

Oncology Reports

Volumn 30, Issue 3, 2013, Pages 1430-1438

  Zhang, Kun Song ^a   Zhou, Qi ^a   Wang, Ya Feng ^a   Liang, Li Jian ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

FRH0212; HCCC 9810; Hilar cholangiocacinoma; RBE; RNA interference; SSP 25; Wnt signaling pathway

Indexed keywords

BETA CATENIN; CYCLIN D1; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR 4; UNCLASSIFIED DRUG; WNT PROTEIN; WNT2 PROTEIN; WNT3 PROTEIN;

APOPTOSIS; ARTICLE; BILE DUCT CARCINOMA; CANCER GENE THERAPY; CANCER INHIBITION; CARCINOMA CELL; CELL CYCLE; CELL PROLIFERATION; CELL STRAIN; CELL STRAIN FRH0201; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYCLIN D1 GENE; DOWN REGULATION; GENE EXPRESSION; GENE TARGETING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; ONCOGENE C MYC; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN RNA BINDING; RNA INTERFERENCE; SIGNAL TRANSDUCTION;

APOPTOSIS; BETA CATENIN; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; BLOTTING, WESTERN; CELL CYCLE; CELL PROLIFERATION; CHOLANGIOCARCINOMA; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNOENZYME TECHNIQUES; MICROSCOPY, FLUORESCENCE; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED; WNT PROTEINS;

EID: 84880630961     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2013.2560     Document Type: Article

References (26)

1. Saxena A, Chua TC, Chu FC and Morris DL: Improved outcomes after aggressive surgical resection of hilar cholangiocarcinoma: a critical analysis of recurrence and survival. Am J Surg 202: 310-320, 2011.
2. Lu D, Zhao Y, Tawatao R, et al: Activation of the Wnt signaling pathway in chronic lymphocytic leukemia. Proc Natl Acad Sci USA 101: 3118-3123, 2004.
3. Ilyas M: Wnt signalling and the mechanistic basis of tumour development. J Pathol 205: 130-144, 2005.
4. Monga SP, Monga HK, Tan X, Mulé K, Pediaditakis P and Michalopoulos GK: Beta-catenin antisense studies in embryonic liver cultures: role in proliferation, apoptosis, and lineage specification. Gastroenterology 124: 202-216, 2003.
5. Micsenyi A, Tan X, Sneddon T, Luo JH, Michalopoulos GK and Monga SP: Beta-catenin is temporally regulated during normal liver development. Gastroenterology 126: 1134-1146, 2004.
6. Monga SP, Pediaditakis P, Mule K, Stolz DB and Michalopoulos GK: Changes in WNT/beta-catenin pathway during regulated growth in rat liver regeneration. Hepatology 33: 1098-1109, 2001.
7. Benhamouche S, Decaens T, Godard C, et al: Apc tumor suppressor gene is the zonation-keeper' of mouse liver. Dev Cell 10: 759-770, 2006.
8. Funato Y, Michiue T, Asashima M and Miki H: The thioredoxin-related redox-regulating protein nucleoredoxin inhibits Wnt-beta-catenin signalling through dishevelled. Nat Cell Biol 8: 501-508, 2006.
9. Lian Z, Liu J, Li L, et al: Enhanced cell survival of Hep3B cells by the hepatitis B x antigen effector, URG11, is associated with upregulation of beta-catenin. Hepatology 43: 415-424, 2006.
10. Higashi N, Kojima N, Miura M, Imai K, Sato M and Senoo H: Cell-cell junctions between mammalian (human and rat) hepatic stellate cells. Cell Tissue Res 317: 35-43, 2004.
11. Guan CN, Chen XM, Lou HQ, Liao XH, Chen BY and Zhang PW: Clinical significance of axin and beta-catenin protein expression in primary hepatocellular carcinomas. Asian Pac J Cancer Prev 13: 677-681, 2012.
12. Kaur P, Mani S, Cros MP, et al: Epigenetic silencing of sFRP1 activates the canonical Wnt pathway and contributes to increased cell growth and proliferation in hepatocellular carcinoma. Tumour Biol 33: 325-336, 2012.
13. Loeppen S, Koehle C, Buchmann A and Schwarz M: A beta-catenin-dependent pathway regulates expression of cytochrome P450 isoforms in mouse liver tumors. Carcinogenesis 26: 239-248, 2005.
14. Tien LT, Ito M, Nakao M, et al: Expression of beta-catenin in hepatocellular carcinoma. World J Gastroenterol 11: 2398-2401, 2005.
15. Tokumoto N, Ikeda S, Ishizaki Y, et al: Immunohistochemical and mutational analyses of Wnt signaling components and target genes in intrahepatic cholangiocarcinomas. Int J Oncol 27: 973-980, 2005.
16. Sugimachi K, Taguchi K, Aishima S, et al: Altered expression of beta-catenin without genetic mutation in intrahepatic cholangiocarcinoma. Mod Pathol 14: 900-905, 2001.
17. Ku JL, Yoon KA, Kim IJ, et al: Establishment and characterisation of six human biliary tract cancer cell lines. Br J Cancer 87: 187-193, 2002.
18. Takiyama I, Terashima M, Ikeda K, et al: Establishment and characterization of a new human extrahepatic bile duct carcinoma cell line (ICBD-1). Oncol Rep 5: 463-467, 1998.
19. Tang WH, Yuan ST, Wang BS, Lu LJ, Ding J and Yuan ZR: Establishment of a subcutaneous model of the human extrahepatic bile duct carcinoma in nude mice via transplantation of histologically intact tumor tissue. J Exp Clin Cancer Res 23: 661-667, 2004.
20. Uematsu K, He B, You L, Xu Z, McCormick F and Jablons DM: Activation of the Wnt pathway in non small cell lung cancer: evidence of dishevelled overexpression. Oncogene 22: 7218-7221, 2003.
21. Davies JA, Ladomery M, Hohenstein P, et al: Development of an siRNA-based method for repressing specific genes in renal organ culture and its use to show that the Wt1 tumour suppressor is required for nephron differentiation. Hum Mol Genet 13: 235-246, 2004.
22. Sangkhathat S, Kusafuka T, Miao J, et al: In vitro RNA interference against β-catenin inhibits the proliferation of pediatric hepatic tumors. Int J Oncol 28: 715-722, 2006.
23. Kim M, Lee HC, Tsedensodnom O, et al: Functional interaction between Wnt3 and Frizzled-7 leads to activation of the Wnt/beta-catenin signaling pathway in hepatocellular carcinoma cells. J Hepatol 48: 780-791, 2008.
24. Mazieres J, You L, He B, et al: Wnt2 as a new therapeutic target in malignant pleural mesothelioma. Int J Cancer 117: 326-332, 2005.
25. Zhao P, Lu Y, Zhong M, Liu L and Li B: Inverse correlation of aberrant expression of fragile histidine triad (FHIT) protein with cyclin D1 protein and prognosis in Chinese patients with cholangiocarcinoma. Acta Oncol 47: 1557-1563, 2008.
26. El-Kady A, Sun Y, Li YX and Liao DJ: Cyclin D1 inhibits whereas c-Myc enhances the cytotoxicity of cisplatin in mouse pancreatic cancer cells via regulation of several members of the NF-κB and Bcl-2 families. J Carcinog 10: 24, 2011.